CGL
Clarius Group LLC Portfolio holdings
AUM
$1.72B
This Quarter Return
+13.98%
1 Year Return
+14.66%
3 Year Return
+85.31%
5 Year Return
+125.74%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$1.21B
(+15%)
Cap. Flow
+$19.3M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
50.02%
Holding
496
New
35
Increased
114
Reduced
290
Closed
19
Top Buys
| 1 |
PACCAR
PCAR
|
$34.2M |
| 2 |
iShares National Muni Bond ETF
MUB
|
$8.81M |
| 3 |
iShares Short-Term National Muni Bond ETF
SUB
|
$3.6M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$2.85M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$2.59M |
Top Sells
| 1 |
Amazon
AMZN
|
$14.2M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$9.49M |
| 3 |
Microsoft
MSFT
|
$3.41M |
| 4 |
Vanguard Ultra-Short Bond ETF
VUSB
|
$3.12M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
$2.88M |
Sector Composition
| 1 | Technology | 18.81% |
| 2 | Industrials | 10.95% |
| 3 | Healthcare | 7.38% |
| 4 | Consumer Discretionary | 6.71% |
| 5 | Financials | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Public Service Enterprise Group
PEG
$40.6B
| $205K | 0.02% |
3,354
-1,016
| -23% | -$62.1K |
|
452
Royal Caribbean
RCL
$95.6B
| $203K | 0.02% |
+1,568
| New | +$203K |
|
453
Henry Schein
HSIC
$8.33B
| $202K | 0.02% |
2,669
-291
| -10% | -$22K |
|
454
Enphase Energy
ENPH
$4.84B
| $201K | 0.02% |
+1,524
| New | +$201K |
|
455
Flywire
FLYW
$1.6B
| $201K | 0.02% |
8,691
-10,016
| -54% | -$232K |
|
456
Exelon
EXC
$43.8B
| $201K | 0.02% |
5,602
-974
| -15% | -$35K |
|
457
Quest Diagnostics
DGX
$20.1B
| $201K | 0.02% |
+1,455
| New | +$201K |
|
458
Iron Mountain
IRM
$26.4B
| $200K | 0.02% |
+2,864
| New | +$200K |
|
459
Dollar Tree
DLTR
$23.2B
| $200K | 0.02% |
+1,408
| New | +$200K |
|
460
Banco Santander
SAN
$140B
| $195K | 0.02% |
47,207
+14,699
| +45% | +$60.9K |
|
461
Sana Biotechnology
SANA
$731M
| $191K | 0.02% |
46,825
| – | – |
|
462
Sumitomo Mitsui Financial
SMFG
$105B
| $177K | 0.01% |
18,286
+5,874
| +47% | +$56.9K |
|
|
SYRS
463
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $145K | 0.01% |
18,620
| – | – |
|
464
Prime Medicine
PRME
$562M
| $142K | 0.01% |
16,080
| – | – |
|
465
Mizuho Financial
MFG
$81B
| $139K | 0.01% |
40,470
+23,488
| +138% | +$80.8K |
|
466
Athira Pharma
ATHA
$14.9M
| $130K | 0.01% |
53,551
+14,124
| +36% | +$34.3K |
|
467
Huntington Bancshares
HBAN
$25.7B
| $128K | 0.01% |
+10,079
| New | +$128K |
|
468
Absci
ABSI
$351M
| $126K | 0.01% |
30,000
| – | – |
|
469
Aegon
AEG
$12B
| $112K | 0.01% |
19,400
| – | – |
|
470
NatWest
NWG
$55.3B
| $110K | 0.01% |
19,556
-1,364
| -7% | -$7.68K |
|
471
Lloyds Banking Group
LYG
$63.1B
| $107K | 0.01% |
44,780
+12,679
| +39% | +$30.3K |
|
472
Uranium Energy
UEC
$4.71B
| $72.7K | 0.01% |
11,357
| – | – |
|
473
SiriusXM
SIRI
$7.73B
| $63.6K | 0.01% |
11,623
+187
| +2% | +$1.02K |
|
474
Telefonica
TEF
$30.1B
| $46.3K | ﹤0.01% |
11,865
-5
| -0% | -$20 |
|
475
Ginkgo Bioworks
DNA
$658M
| $30K | ﹤0.01% |
17,761
| – | – |
|